KUZIK SI DIMOSTRA EFFICACE NELLA PREVENZIONE DELL' EMICRANIA SENZA AURA

Data: 05 Maggio 2019

Autore: Vincenzo Tullo, Marcella Curone,Bruno Colombo,Gianni Allais,Davide Zarcone,Maria Gabriella Saracco,Gennaro Bussone

Fonte: NEUROLOGICAL SCIENCES

KUZIK SI DIMOSTRA EFFICACE NELLA PREVENZIONE DELL' EMICRANIA SENZA AURA

Lo studio sara' presentato al congresso stresa headache 2019

Our study has demonstrated the efficacy of Kuzik® in the improvement of episodic MO with a reduction at
least of 50% in the frequency of attacks per month (51%) and in MIDAS disability score (84%). Kuzik®
was well tolerated and allowed a reduction of 50% of symptomatic drug assumptions in 43% of patients treated.
On the basis of these data, we suggest that the use of Kuzik® may have a role in the prophylactic treatment
of MO.

Prodotti in farmacia

disponibili in farmacia
e parafarmacia